Gastric cancer in Durham, North Carolina

The Duke Cancer Center Gastrointestinal (GI) Clinic, located at 20 Duke Medicine Circle in Durham, North Carolina, is a specialized health institution dedicated to providing consultations and care for individuals suspected or diagnosed with cancers of the GI tract. Our team of experts includes medical oncologists, surgical oncologists, radiation oncologists, and other specialists who work together to ensure the best possible outcome for each patient. We offer timely appointments, comprehensive care coordination, and access to cutting-edge treatments and clinical trials. In addition to medical services, we provide a range of support programs and resources to address the holistic needs of our patients. Our facility is easily accessible via public transportation, and we offer free interpreter services for non-English speaking patients. At Duke Cancer Center Gastrointestinal (GI) Clinic, your health and well-being are our top priorities.

Michael A. Morse, MD, FACP, MHS is a renowned doctor specializing in immune therapies for various types of cancers. Located at 2301 Erwin Road in Durham, North Carolina, United States, Dr. Morse's institution offers cutting-edge treatments for solid tumors such as colorectal, pancreatic, breast, ovarian, prostate, lung cancers, and melanoma. Clinical trials for new drugs targeting cancers like hepatocellular carcinoma, cholangiocarcinoma, neuroendocrine tumors, and colorectal, pancreatic, and gastric cancers are also conducted here. Patients at Dr. Morse's practice can expect high-quality care and treatment, as evidenced by the institution's Patient Rating score, which is based on responses to care provider related questions on a nationally-recognized Press Ganey Patient Satisfaction Survey. Duke Health, where Dr. Morse practices, accepts most major health insurance carriers and transplant networks.

Manisha Palta, MD is a radiation oncologist located at 2301 Erwin Road in Durham, North Carolina, United States. Specializing in treating patients with gastrointestinal cancers and breast cancer, Dr. Palta also conducts clinical research trials focused on the impact of exercise on cancer growth and treatment side effects. With a passion for helping people, Dr. Palta enjoys interacting with patients and explaining how radiation therapy works to benefit them. Her goal is to provide patients with a clear understanding of their treatment to reduce anxiety and fear. Patient satisfaction is a top priority, as evidenced by her high Patient Rating score. Dr. Palta's research interests include exploring the effects of physical activity on cancer treatment outcomes and utilizing advanced radiotherapy planning techniques. Duke Health accepts most major health insurance carriers, making quality care accessible to all patients.

Tucker W. Coston, MD is a medical institution located at 20 Duke Medicine Circle in Durham, North Carolina, United States. Specializing in treating cancers of the gastrointestinal (GI) tract and associated organs, Dr. Coston delivers medical oncology care including discussions of new cancer diagnoses, coordinating initial work-ups, and collaborating with other cancer specialists such as radiation oncologists and surgeons. As a medical oncologist, Dr. Coston administers medications to treat cancer, including IV chemotherapy, oral chemotherapy, immunotherapy, and other non-chemo treatments. He is a leading specialist in the treatment of neuroendocrine tumors (NETs) at Duke Raleigh Cancer Center and conducts clinical trials to offer patients cutting-edge treatment options. With a commitment to providing quality care with attention to detail, Dr. Coston's research focuses on improving outcomes for patients with GI cancers through innovative diagnostic and treatment strategies. Duke Health accepts most major health insurance carriers, ensuring accessibility to quality care for patients.

Nicholas C. DeVito, MD is a medical oncologist located at 20 Duke Medicine Circle in Durham, North Carolina, United States. Specializing in the treatment of colorectal, pancreatic, and esophagogastric cancers, Dr. DeVito also conducts research on tumor immunology and immunotherapy. With a background in cancer vaccine research and a focus on laboratory-based and translational research, Dr. DeVito aims to find new immunotherapeutic options for patients with supportive biomarkers. In the clinic, he offers innovative therapies and shared decision-making processes to provide the best care for his patients. Dr. DeVito's research focuses on understanding how cancers evade the immune system when they spread, particularly in colon and gastroesophageal cancers. By identifying markers that can predict which patients will benefit from different immunotherapies, he hopes to improve treatment options and outcomes for cancer patients. Duke Health accepts most major health insurance carriers, ensuring that patients have access to the care they need.